Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PreOperative Endocrine Therapy for Individualised Care With Abemaciclib

Trial Profile

PreOperative Endocrine Therapy for Individualised Care With Abemaciclib

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abemaciclib (Primary)
  • Indications Early breast cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms POETIC-A
  • Most Recent Events

    • 19 Dec 2022 Planned primary completion date changed from 30 Mar 2026 to 30 Sep 2030.
    • 19 Dec 2022 Planned End Date changed from 30 Sep 2028 to 31 Mar 2032.
    • 19 Dec 2022 The recruitment end date has been changed from 23/12/2023 to 30/09/2026.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top